Skip to main content

Table 1 Baseline characteristics of 692 HIV-positive illicit drug users stratified by adherence to ART in the previous six months

From: Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis

Characteristic <95% adherence ≥95% adherence OR1 95% CI2 pvalue
301 (43.5) n (%) 392 (56.6) n (%)
Age      
Median (IQR) 40 (34 – 45) 43 (36 – 48) 1.05 1.02 – 1.06 <0.001
Gender      
Male 195 (64.8) 284 (72.6) 1.00   
Female 106 (35.2) 107 (27.5) 0.69 0.50 – 0.96 0.027
Caucasian ancestry      
No 143 (47.5) 140 (35.8) 1.00   
Yes 158 (52.5) 251 (64.2) 1.62 1.19 – 2.20 0.002
Heroin injection3      
No 141 (47.0) 211 (54.1) 1.00   
Yes 159 (53.0) 179 (45.9) 0.75 0.56 – 1.02 0.064
Cocaine injection3      
No 126 (41.9) 178 (45.5) 1.00   
Yes 175 (58.1) 213 (54.5) 0.86 0.64 – 1.17 0.336
Amphetamine injection3      
No 271 (90.0) 337 (86.2) 1.00   
Yes 30 (10.0) 54 (13.8) 1.45 0.90 – 2.33 0.125
Crack cocaine smoking3      
No 107 (35.5) 134 (34.2) 1.00   
Yes 194 (64.5) 257 (65.7) 1.06 0.77 – 1.45 0.727
MMT3      
No 202 (67.1) 210 (53.7) 1.00   
Yes 99 (32.9) 181 (46.3) 1.76 1.29 – 2.40 <0.001
Time since ART initiation (per year) 5.1 (2.5 – 8.9) 6.5 (3.1 – 11.4) 0.94 0.91 – 0.97 <0.001
Median (IQR)      
CD4+ cells at ART initiation      
Median (IQR) 260 (150 – 390) 220 (140 – 360) 1.00 1.00 – 1.00 0.074
  1. 1. Odds Ratio; 2. 95% Confidence Interval; 3. Refers to 180 day period prior to the baseline interview.